Dr. Mina Izadyar (Persian: دکتر مینا ایزدیار) was a prominent Iranian professor[1][2] and pediatrician in the field of hematology and oncology. Her efforts and research alongside her colleagues resulted in the reduction of live-born infants with acute Thalassemia from 2500 to just 300 per year. She was also co-founder and director of Iranian Thalassemia Society[3][4]
Dr.Mina Izadyar | |
|---|---|
| Born | Mina Izadyar October 1, 1949 |
| Died | June 21, 2013 (aged 63) |
| Nationality | Iranian |
| Education | Hematologist-Oncologist |
| Occupation(s) | Founder and Chairwoman of the Iranian Thalassemia Society |
| Spouse | Parviz Malekpour |
Career
editThroughout her life, Izadyar had many notable achievements. She was the founder of the Iranian Thalassemia Society,[5] co-founder of Iranian Pediatric Hematology-Oncology Society and member of its executive board, a professor at Shahid Beheshti University of Medical Sciences, a pediatrician, a hematologist-oncologist, the chairwoman of the Iranian Thalassemia Society's board of directors, a ward manager at a number of top Tehran hospitals and the head of hematology-and-oncology ward at Children's Medical Center [affiliated to Tehran University of Medical Sciences] and member of Mahak Board of Trustees.[6][3] There have been many publications left from her work and research.[7] She has also contributed to the book The Thalassaemia Syndromes. One of her notable colleagues, Mardawig Alebouyeh describes her achievements as: "Collaboration with other colleagues in planning and setting-up programs to curb the incidence of major beta-thalassemia as a major social health problem in Iran. These programs, which have been approved and supported by health authorities, include premarital screening for beta-thalassemia trait, which is enforced by law and applied country-wide as well as prenatal diagnosis and abortion of homozygous fetus. Furthermore, she initiated, established and directed the Iranian Thalassemia Society which supervised and enforced the application of standard treatment protocols for patients with major beta-thalassemia throughout the country. By engaging personal energy and perseverance she was able to establish adjacent to each Blood Transfusion center in Iran a specialized clinic to provide medical care, supervision and blood transfusion. Through her relentless effort in significantly reducing cases of live-born infants with acute thalassemia (now 300 vs. 2500 per year before), elder thalassemia patients now enjoy a better life quality, much higher life expectancy and more active social partnership as a result".[3]
Religion
editMina was a Zoroastrian. Her husband also served as the Zoroastrians representative member of parliament in Iran.
Death
editIzadyar died from cancer on 21 June 2013.[5] There has been many scientists in the field who expressed their condolences after her death which were published by Thalasemia International Federation.[8] It was also announce by Sorena Sattari that a research chair in memory of her will be established.[6][2]
See also
editReferences
edit- ^ "Mina Izadyar - Tehran University of Medical Sciences". Archived from the original on 2017-12-29. Retrieved 2017-12-29.
- ^ a b "Mina Izadyar Research Chair calls for research proposals". 22 July 2015. Archived from the original on 30 December 2017. Retrieved 30 December 2017.
- ^ a b c "In Memoriam: Mina Izadyar, M.D." mahak-charity.org. Archived from the original on 2016-06-07.
- ^ "EDUCATIONAL MATERIALS ON HAEMOGLOBINOPATHIES: BETA THALASSAEMIA". Archived from the original on 10 July 2024. Retrieved 10 July 2024.
- ^ a b "Irannian National Science Foundation - News > Call for research proposals for "Mina Izadyar" research chair award in Hematology". Archived from the original on 2017-12-29. Retrieved 2017-12-29.
- ^ a b "A research chair is to be set up in memory of late Mina Izadyar". ifpnews.com. Archived from the original on 2017-12-25.
- ^ "Mina Izadyar's research works | University of Tehran, Tehran (UT) and other places". Retrieved 2022-05-03.
- ^ "Log in or sign up to view". www.facebook.com.